Parkinson's Disease Flashcards
What is the pathophysiological and macroscopical aspect of parkinsons disease?
loss of pigmented dopamine neurons in striatum, because no input from subst. nigra»_space; less inhibition of GPi, making it overreactive»_space;increased inhibtion of thamalus»_space; hypokinesia
decreased pigmentation on substantia nigra and locus ceruleus
lewy bodies: abnormal aggragation of proteins
Which mechanisms lead to neuronal loss in PD?
oxidative stress mitochondrial dysfunction excitotoxicity glial cell activation apoptosis
What is parkinsons disease?
progressive, multifocal neurodegenerative disease
- dopaminergic/non dopaminergic
- CNS/ PNS affected
How is the progression of the lewy inclusion bodies?
typical pregression from: medulla»_space; pons»_space; midbrain»_space; mesocortex»_space; neocortex
Etiology of parkinson disease
genes, toxins, endogenous, trauma
Epidemiology of parkinson disease
onset: 40 - 70 yea, peak in 6th decade
M>F
What are the early signs of parkinson disease
- stiffness
- pain and paresthesia of limb
- constipation
- sleeplessness
- decr. voice volume
others: decr. fine motor skills and sense of smell, loss of appetite, tremor with anxiety
Clinical subtypes of parkinson disease
- young age and slow progression
- old age and fast progression
- tremor dominant
- postural instability and gait difficulty
How is the posture of a patient in parkinson disease
flexed posture, less of reflexes, no balance, festination, freezing phenomenon
What are the clinical signs of dementia with lewy bodies
- fluctuating attention and alertness episodes
- halluzinations
- parkinsonian motor features
- early extrapyr. features (in alzheimer they are late)
- less prominent anterograde memory loss (in alzheimer is prominent)
- executive function deficits
How to differentiate between dementia with lewy bodies and parkinson disease?
parkinson: parkinsonian signs are present more than 12 month before cognitive impairment
DLB: parkinsonian signs are seen less than 12 month before cognitive impairment
Treatment of parkinsons disease
dopaminergic agents:
- levodopa
- dopamine agonists (ergot and non-ergot)
- selective MAO-B inhibitors
non dopamin. agents:
- anticholinergic agents
- n-methyl-di-aspartate antagonist
describe pyramidal spasticity and parkinsonian rigidity
spasticity:
lesion in corticospinal pathway, unidirectional, passive movement speed dependent, UMN lesion
claspknife phenomenon: initial rigidity during passive movement, at sharp angel resistance disappears suddenly
rigidity:
extrapyramidal lesion, referred to lesion in basal ganglia, bidirectional, not speed dependent, rigidity present during whole passive movement,
leadpipe rigidity: rigidity from beginning to end of movement
cogwheel rigidity: rigidity with interposed tremor signs (parkinon feature)
plasticity: newly places limb stays in that position
features of parkinson tremor
typical rest tremor, 4 - 6 Hz
most prominent at distal part of extremity
pill rolling tremor
exacerbated during provocation
features of progressive supranuclear palsy
supranuclear ophtalmoplegia pseudobulbar palsy prominent neck dystonia parkinsonism impaired postural reflexes